List of Legends
Refer to the full list of legends here.
Last updated 24 April 2026
Subsidy Information and Financing Scheme
This section shows the following:
Subsidy Scheme and Clinical Indication (where applicable) of drugs listed in the MOH List of Subsidised Drugs
Subsidised brands of vaccines recommended in the National Immunisation Schedules listed in the MOH Subsidised Vaccine List
Cancer Drug and Clinical Indication listed in the MediShield Life Cancer Drug List
As this website is updated monthly, please refer to MOH List of Subsidised Drugs, MOH Subsidised Vaccine List or MediShield Life Cancer Drug List for the most updated information.
Legend list
Indicator | Legend |
|---|---|
SDL | Standard Drug List |
MAF | Medical Assistance Fund |
SVL | Subsidised Vaccine List |
MSHL | Cancer Drug and Clinical Indication listed in the MediShield Life Cancer Drug List |
Drug Guidance for Subsidy
This section displays recommendation from the MOH Drug Advisory Committee for subsidy and appropriate use of the drug as extracted from the Agency for Care Effectiveness (ACE) Drug Guidances. As this website is updated monthly, please refer to the ACE website for the most updated information.
Legend list
Indicator | Legend |
|---|---|
R | Recommended for subsidy |
NR | Not recommended for subsidy |
Post Marketing Information
Educational materials for healthcare professionals
Educational materials highlight specific safety concerns associated with the use of selected therapeutic products and provide advice on the actions required to optimize safe and effective use of these products.
Only educational materials approved by the Health Sciences Authority of Singapore (HSA) are listed. These materials are published with the agreement of the company responsible for producing them and are not intended to replace medical advice offered by healthcare professionals (HCP). As this website is updated monthly, please refer to HSA website for the most updated information.
Dear Healthcare Professional Letters (DHCPLs)
Dear Healthcare Professional Letters (DHCPL) are letters issued by a manufacturer or the HSA to healthcare professionals to communicate new or emerging safety, efficacy or quality information associated with the use of specific marketed therapeutic products. As this website is updated monthly, please refer to HSA website for the most updated information.